Literature DB >> 3366164

Aldosterone response to metoclopramide is mediated through the autonomic nervous system in man.

D K Sommers1, E C Meyer, M van Wyk, L S de Villiers.   

Abstract

This study primarily examines the role of the autonomic nervous system in the aldosterone response to metoclopramide since there is conflicting evidence as to the involvement of a dopaminergic mechanism in this response. Six normal male volunteers in metabolic balance at 100 mmol sodium/day and 60 mmol potassium/day constant intake received metoclopramide, 10 mg i.v., on five different occasions. The dosing was either metoclopramide alone or combined with ganglionic, muscarinic, beta-adrenergic or calcium-channel blockade. Metoclopramide increased serum aldosterone significantly to 163.3% of basal level at 10 min. Atropine blunted this response and the 10 min level was significantly reduced to 116.03% of the basal value. The highest aldosterone levels were attained when metoclopramide was administered during a trimethaphan infusion and a peak of 292.8% of basal level occurred at 90 min. In the presence of atenolol, with or without nifedipine, the metoclopramide-induced aldosterone response was significantly greater at 15 min than with metoclopramide alone. The results of this investigation suggest that the aldosterone response to metoclopramide is mediated by acetylcholine released from post-ganglionic cholinergic nerve terminals, and that an adrenergic mechanism exerts a tonic inhibitory influence on aldosterone secretion in man.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366164     DOI: 10.1007/bf00542496

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  The structure and function of adrenal autotransplants.

Authors:  R D Wright; J R Blair-West; J P Coghlan; D A Denton; J W Funder; J R Goding; J F Nelson; B A Scoggins
Journal:  Aust J Exp Biol Med Sci       Date:  1972-12

2.  Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine.

Authors:  E Rolandi; G Marchetti; R Franceschini; V Cicchetti; R Gianrossi; V Cantoni; T Barreca
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Lack of direct effect of dopamine on aldosterone secretion in vivo.

Authors:  S Lun; E A Espiner; M G Nicholls; D S Hart
Journal:  Endocrinology       Date:  1983-01       Impact factor: 4.736

4.  Dopaminergic inhibition of aldosterone secretion in man is independent of the autonomic nervous system.

Authors:  T A Wilson; D L Kaiser; R M Carey
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

5.  Stimulation of aldosterone secretion by metoclopramide is not affected by chronic converting enzyme inhibition.

Authors:  A G Dupont; P Vanderniepen; J J Smitz; R O Six
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Metoclopramide increases plasma aldosterone concentration in man.

Authors:  G Norbiato; M Bevilacqua; U Raggi; P Micossi; C Moroni
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

7.  Stimulation of aldosterone secretion by metoclopramide in humans: apparent independence of renal and pituitary mediation.

Authors:  J H Pratt; A Ganguly; C A Parkinson; M H Weinberger
Journal:  Metabolism       Date:  1981-02       Impact factor: 8.694

8.  Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.

Authors:  R M Carey; M O Thorner; E M Ortt
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

9.  Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.

Authors:  R M Carey; M O Thorner; E M Ortt
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

10.  Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes.

Authors:  M B Gordon; T J Moore; R G Dluhy; G H Williams
Journal:  Clin Endocrinol (Oxf)       Date:  1983-10       Impact factor: 3.478

View more
  5 in total

1.  Effect of neostigmine on metoclopramide-induced aldosterone secretion in man.

Authors:  D K Sommers; E C Meyer; M van Wyk
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  The effect of neostigmine on metoclopramide-induced aldosterone secretion after the administration of muscarinic antagonists in man.

Authors:  D K Sommers; E C Meyer; M van Wyk
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Effect of metoclopramide, ondansetron and granisetron on aldosterone secretion in man.

Authors:  D K Sommers; J R Snyman; M van Wyk
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Atrial natriuretic factor inhibits metoclopramide stimulated aldosterone release in man.

Authors:  C C Lang; A R Rahman; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

5.  Metoclopramide-induced cardiac arrest.

Authors:  Martha M Rumore; Spencer Evan Lee; Steven Wang; Brenna Farmer
Journal:  Clin Pract       Date:  2011-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.